In particular, hyperammonemia leads to mitochondrial dysfunction that increases reactive oxygen species formation and subsequently oxidative stress, damage and breakdown of muscle protein and lipid; therefore, hyperammonemia decreases muscle protein synthesis by, among other pathway mechanisms, myostatin activation, a myokine [91,92,93,94]. Here, MSTN is linked to Hyperammonemia.